SNY Jan 2025 45.000 call
| Previous close | 13.00 |
| Open | 13.00 |
| Bid | 9.70 |
| Ask | 13.00 |
| Strike | 45.00 |
| Expiry date | 2025-01-17 |
| Day's range | 13.00 - 13.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 81 |
ZacksPharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
BloombergSanofi Healthcare Bidders Revising Offers Over Talc Concerns
(Bloomberg) -- Bidders for Sanofi’s consumer healthcare unit are revising their offers in part to address concerns around potential liabilities related to a brand that sold talcum powder, according to people with knowledge of the matter. Most Read from BloombergWhat Do US Vehicle Regulators Have Against Tiny Cars?Mexico City Restricts Airbnb Rentals to Curb ‘Gentrification’Singapore Ends 181 Years of Horse Racing to Make Way for HomesFor a Master of Brutalist Provocations, a Modest Museum Apprai
BloombergSanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply
(Bloomberg) -- GSK Plc, Sanofi and CSL Ltd. secured $72 million from the US government to ramp up production of bird flu vaccines as a nationwide outbreak among livestock and poultry has led to several human infections that have raised concerns about further spread.Most Read from BloombergWhat Do US Vehicle Regulators Have Against Tiny Cars?Mexico City Restricts Airbnb Rentals to Curb ‘Gentrification’Singapore Ends 181 Years of Horse Racing to Make Way for HomesFor a Master of Brutalist Provocat
